Correlation Between Ikena Oncology and PepGen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ikena Oncology and PepGen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ikena Oncology and PepGen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ikena Oncology and PepGen, you can compare the effects of market volatilities on Ikena Oncology and PepGen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ikena Oncology with a short position of PepGen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ikena Oncology and PepGen.

Diversification Opportunities for Ikena Oncology and PepGen

0.9
  Correlation Coefficient

Almost no diversification

The 3 months correlation between Ikena and PepGen is 0.9. Overlapping area represents the amount of risk that can be diversified away by holding Ikena Oncology and PepGen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PepGen and Ikena Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ikena Oncology are associated (or correlated) with PepGen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PepGen has no effect on the direction of Ikena Oncology i.e., Ikena Oncology and PepGen go up and down completely randomly.

Pair Corralation between Ikena Oncology and PepGen

Given the investment horizon of 90 days Ikena Oncology is expected to generate 0.22 times more return on investment than PepGen. However, Ikena Oncology is 4.6 times less risky than PepGen. It trades about -0.13 of its potential returns per unit of risk. PepGen is currently generating about -0.11 per unit of risk. If you would invest  173.00  in Ikena Oncology on November 28, 2024 and sell it today you would lose (33.00) from holding Ikena Oncology or give up 19.08% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy100.0%
ValuesDaily Returns

Ikena Oncology  vs.  PepGen

 Performance 
       Timeline  
Ikena Oncology 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Ikena Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
PepGen 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days PepGen has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Ikena Oncology and PepGen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ikena Oncology and PepGen

The main advantage of trading using opposite Ikena Oncology and PepGen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ikena Oncology position performs unexpectedly, PepGen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PepGen will offset losses from the drop in PepGen's long position.
The idea behind Ikena Oncology and PepGen pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Complementary Tools

Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Global Correlations
Find global opportunities by holding instruments from different markets
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.